Top mining stocks to add to your portfolio
Professional investors Keith Watson and Rob Crayfourd of CQS Natural Resources Growth and Income tell us where they’d put their money.

CQS Natural Resources is a £154 million investment trust focused on global energy and mining equities. We pick the commodities we are most bullish on and the stocks we think are most attractively valued. In normal times valuations are reflective of a bullish commodity outlook, but we believe distortions in the market led by an increased focus on the environment have allowed us to find attractively priced stocks in commodities we expect to appreciate.
This is driven by several factors. Institutions have sold fossil-fuel producers owing to constraints imposed by environmental, social and governance (ESG) criteria, while banks don’t want to lend to the sector, meaning the stocks are cheap and new supply remains constrained. Similarly, sentiment for precious metals miners continues to remain weak despite gold at all-time highs. These both create attractive opportunities.
Mining stocks to add to your portfolio
NexGen Energy (Toronto: NXE) is a Canadian-listed, £3 billion uranium miner with the best undeveloped mine in the world in Canada’s Athabasca basin. Uranium is used for nuclear power, the only zero-carbon form of base-load power. Demand for atomic energy is set to grow in the West as countries realise it will be crucial to meeting carbon-reduction targets.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This means reactors in the West will continue to see life extensions, with small modular reactors (SMRs) becoming an additional driver at the end of the decade. China continues to build 10 reactors per year, partly for energy-security purposes, supporting demand. Supply growth remains constrained given years of underinvestment in exploration and development, while long permitting timelines for uranium should also help sustain tight markets and high prices for years to come.
Australia’s Emerald Resources (Sydney: EMR), worth £1.3 billion, is a gold producer in Cambodia with an asset in Australia. Funded by cashflows from their low-cost Cambodian gold mine, the Australian project should support a rerating of the stock as well as a strong pipeline for self-funded future growth. Cambodia also offers growth potential, with some exciting new discoveries. This best-in-class management team can build new mines more rapidly and cheaply than its peers, as evidenced by the seven mines they have built previously. CEO Morgan Hart owns £74 million of stock, remaining heavily aligned with shareholders. This stock has been one of the strongest performers in the sector, but we retain our position as the company should continue to deliver healthy organic growth over the next four to five years.
Emerging markets boost demand for oil
Consider also Transocean (NYSE: RIG), a £3.5 billion US-listed offshore rig operator. We like sectors with structural supply constraints while demand is projected to improve. Offshore rigs fit the bill. No one is building new large offshore rigs, as current rigs trade at around 50% of their new-build cost, while the lead time on a new build is seven years and there is no certainty of future demand or support from banks in thrall to the ESG agenda. Demand is projected to rise as emerging markets, especially India and China, require more oil, leading to stronger investment by the oil majors.
Day rates have already increased from $100,000 per day to around $500,000 for Transocean’s high-end rigs, where the group dominates the market. But the nature of long-term contracts means this will continue to feed through as contracts roll over into newer, more expensive contracts over the next couple of years
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Keith joined CQS in July 2013 from Mirabaud Securities where he was a Senior Natural Resource Analyst. Prior to Mirabaud, Keith was Director of Mining Research at Evolution Securities.
Previous to this, he was a top-ranked business services analyst at Dresdner Kleinwort Wasserstein, Commerzbank and Credit Suisse/BZW. Keith began his career in 1992 as a portfolio manager and research analyst at Scottish Amicable Investment Managers. Keith holds a BSc (Hons) in Applied Physics from Durham University.
Keith Watson is a co-Fund Manager for CQS Natural Resources Growth and Income plc, Geiger Counter and Golden Prospect Precious Metals.
-
Review: Trasierra – a yoga retreat in the Spanish hills
Flora Connell joins a yoga retreat at Trasierra, in the Sierra Morena mountains north of Seville
By Flora Connell Published
-
How much should I have in emergency savings?
When your boiler breaks or your car won’t start, you can find yourself paying a hefty bill. How much should you have in emergency savings to cover unexpected costs?
By Katie Williams Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published